Hemophilia B is a rare blood disorder. It happens when the body doesn't have enough of a protein called Factor IX. This protein is needed to help blood clot properly. Without enough Factor IX, people with Hemophilia B are at higher risk of bleeding, especially in the joints and muscles. It's usually inherited from a parent.
Every report comes from a Lived member, sent anonymously.
Have you tried Factor IX Concentrates for Hemophilia B?
Hemophilia B is an inherited bleeding disorder in which the blood is low in clotting factor IX (factor 9), one of the proteins that work together to seal a damaged blood vessel. Without enough of it, a clot forms slowly or poorly, so bleeding lasts longer than it should. That can mean prolonged oozing after a cut, a tooth extraction or surgery, bleeding that starts again after it seemed to stop, and bleeding inside the body, especially into joints and muscles. It is also known as Christmas disease, and it is less common than hemophilia A, which involves factor VIII instead. How much hemophilia B affects someone depends on how much working factor IX they have, measured as a percentage of normal. In severe hemophilia B (below 1 percent), bleeding into the knees, elbows, ankles and muscles can happen without any obvious injury. In moderate hemophilia B, spontaneous bleeds are less frequent, but minor injuries can cause prolonged bleeding. In mild hemophilia B (above 5 percent but below normal), spontaneous bleeding is unusual, and the problem may only come to light after surgery, dental work or a serious injury, sometimes in adulthood.
Hemophilia B is caused by a change (variant) in the F9 gene, which carries the instructions for making factor IX. The gene sits on the X chromosome, which shapes who is affected. Males have one X chromosome, so a single altered copy causes hemophilia B. Females have two, so they are usually carriers rather than fully affected, but that word can understate things: about 3 in 10 carriers have factor IX levels low enough to put them at risk of bleeding, for example after surgery, dental work or childbirth. A mother who carries the variant has a 50 percent chance of passing it on in each pregnancy. A father with hemophilia B passes it to all of his daughters and none of his sons. Because the disorder is present from birth, bleeds are set off by everyday events rather than caused by them: injuries, surgery, dental work, injections into a muscle and, in severe hemophilia, sometimes nothing identifiable at all.
Hemophilia B is usually suspected because of unusual bleeding or a family history. Severe hemophilia B is usually diagnosed within the first two years of life, often after bleeding with circumcision, heavy bruising, or swollen joints once a baby starts crawling and walking. Moderate hemophilia is usually found in early childhood, while mild hemophilia may not be found until later in life. Testing starts with screening clotting tests, including the partial thromboplastin time (PTT), which measures how long a blood sample takes to clot and is often prolonged in hemophilia. The diagnosis is made with a factor IX activity test, which reports how much working factor IX is in the blood as a percentage of normal. That number also sets the severity, so it guides treatment. Genetic testing can identify the specific F9 variant. That confirms the diagnosis and makes it possible to test relatives, including female relatives who may carry the variant. It also allows testing before or during a pregnancy. Female relatives are best tested before pregnancy, or as early in it as possible, so plans for delivery can be made.
There is no cure, but treatment can prevent most bleeding and protect the joints. The cornerstone is replacing the missing protein with factor IX concentrate, given by infusion into a vein. It is made from donated plasma or produced in a laboratory (recombinant). Longer-lasting versions, such as Alprolix, allow preventive doses to be spaced about a week or more apart. Factor can be used in two ways. Prophylaxis means regular preventive infusions that keep levels high enough to prevent most bleeds. It is standard for severe hemophilia B and for others who bleed often, because preventing repeated joint bleeds prevents lasting joint damage. On-demand treatment means giving factor when a bleed happens, and it works best given as soon as possible after symptoms start. Many families learn to give infusions at home. Newer preventive medicines work differently. Rather than replacing factor IX, they ease the body's natural brakes on clotting, and they are injected under the skin. Marstacimab (Hympavzi) is given weekly from age 6. Concizumab (Alhemo) is given daily from age 12. Fitusiran (Qfitlia) is given from age 12, starting every two months, with the dose and schedule adjusted by blood tests. These medicines can make prevention easier for people who struggle with frequent vein infusions. They are also an option when factor IX has stopped working because of inhibitors (antibodies against infused factor IX). Because they push the balance toward clotting, they carry a risk of unwanted blood clots, particularly when extra factor is used for a breakthrough bleed. Fitusiran also carries a warning for gallbladder disease. A plan for treating breakthrough bleeds should be agreed in advance. Gene therapy with etranacogene dezaparvovec (Hemgenix) is a one-time infusion that delivers a working factor IX gene to the liver so the body can make its own. It is approved for adults who need regular prophylaxis or have had serious bleeds, and is not given to people who have or have had factor IX inhibitors. Most people end up with factor levels in the mild hemophilia range, but results vary widely. It requires liver blood tests weekly for three months and then monthly for the rest of the first year, because the liver can become inflamed and this can reduce how well the treatment works. A small number of people, mostly those with severe hemophilia B, develop inhibitors: antibodies that make infused factor IX stop working. In hemophilia B, inhibitors can come with severe allergic reactions to factor and, less often, kidney problems, so a specialist team manages them. Physical therapy helps recover strength and movement after joint and muscle bleeds.
Hemophilia B is lifelong, but with modern treatment most people go to school, work, exercise and lead a fairly normal life. The day-to-day burden depends largely on severity and on the treatment chosen. For someone on prophylaxis, routine means scheduled infusions or injections, keeping a record of bleeds, and knowing how to treat a bleed quickly. People with mild hemophilia may need little routine treatment but still need a plan before surgery, dental work or childbirth. Joints are the main long-term concern. Repeated bleeds into the same joint can cause lasting pain and stiffness and, over years, may lead to the need for joint replacement. Preventive treatment, prompt treatment of bleeds and physical therapy after a bleed all help protect them. Medicines and herbal remedies that affect platelets, including aspirin, can make bleeding worse, so check with the care team before taking new pain relievers. Contact sports and activities with a high risk of head injury deserve a careful conversation. Care is usually coordinated through a hemophilia treatment center, a specialist clinic that brings together hematologists, nurses, physical therapists and genetic counselors. Children with moderate or severe hemophilia are usually seen every 6 to 12 months, and adults at least once a year. People with mild hemophilia are usually seen every one to two years. Visits review bleeds, adjust treatment, check joints and screen for inhibitors. Women who carry the variant benefit from a delivery plan, because their factor IX level does not rise much during pregnancy and they may need treatment around childbirth.
Arrange an evaluation for unusual bruising, bleeding that is hard to stop after cuts, dental work or surgery, or swollen painful joints, especially if a relative has hemophilia B. If hemophilia runs in your family, get tested before a planned pregnancy, a surgery or a circumcision. Contact your hemophilia treatment center right away for signs of a joint or muscle bleed. These include a joint that feels tight, swollen or painful, trouble using an arm or leg, or a young child who suddenly refuses to crawl or walk. Also call right away if bleeding keeps coming back, or if a treatment seems to be working less well than usual. Treat early according to your plan rather than waiting to be sure. A blow to the head, even one that seems minor, is an emergency for anyone with hemophilia B. So are a severe or unusual headache, vomiting, unusual sleepiness, passing out or a seizure, with or without a known injury, because these can signal bleeding in the brain. Give factor if you have a home plan that covers this, then call 911 or go to the emergency department right away. Tell staff about the hemophilia: factor treatment should not be delayed while waiting for scans. Bleeding in the neck or throat, or heavy bleeding that will not stop, also needs emergency care.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hemophilia B is like, what's helped you, or ask the community a question.